MSCV-Mycn-IRES-GFP Citations (1)

Originally described in: A mouse model of the most aggressive subgroup of human medulloblastoma.
Kawauchi D, Robinson G, Uziel T, Gibson P, Rehg J, Gao C, Finkelstein D, Qu C, Pounds S, Ellison DW, Gilbertson RJ, Roussel MF Cancer Cell. 2012 Feb 14;21(2):168-80. PubMed Journal

---

Articles Citing MSCV-Mycn-IRES-GFP

Articles
Heterozygous Kmt2d loss diminishes enhancers to render medulloblastoma cells vulnerable to combinatory inhibition of LSD1 and OXPHOS. Dhar SS, Brown C, Rizvi A, Reed L, Kotla S, Zod C, Abraham J, Abe JI, Rajaram V, Chen K, Lee MG. Cell Rep. 2025 May 27;44(5):115619. doi: 10.1016/j.celrep.2025.115619. Epub 2025 Apr 25. PubMed

If you have published an article using this material, please email us at to have your article added to this page.